Skip to main content
SpringerLink
Log in

Current Management of Ductal Carcinoma In Situ (DCIS)

  • Chapter
  • First Online:
Breast Disease

  • 2296 Accesses

Abstract

Ductal carcinoma in situ (DCIS) is the earliest described form of breast cancer, and despite tremendous research into this enigmatic disease process, that continues to puzzle researchers and clinicians around the world. Some clinicians clearly think that we are overtreating DCIS, from the initial screening stages through the surgical management. Although we all recognize the seemingly innocuous natural history of DCIS, we all know of patients that have initially presented with DCIS whom have ultimately died from their disease. Given this, until we are capable of developing better prognostic features that can definitively determine those that will (and will not) go on to develop progressive invasive disease, we are obligated to treat all patients with DCIS (all grades) who present with this noninvasive form of breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 189.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ernster VL, Barclay J, Kerlikowske K, et al. Mortality among women with DCIS of the breast in the population-based surveillance, epidemiology and end-results program. Arch Intern Med. 2000;160(7):953–8.

    Article  CAS  PubMed  Google Scholar 

  2. Fisher ER, Land SR, Saad RS, et al. Pathologic variables predictive of breast cancer events in patients with DCIS. Am J Clin Pathol. 2007;128(1):86–91.

    Article  PubMed  Google Scholar 

  3. Yen MF, Tabar L, Vitak B, et al. Quantifying the potential problem of overdiagnosis of DCIS in breast cancer screening. Eur J Cancer. 2003;39(12):1746–54.

    Article  PubMed  Google Scholar 

  4. Duffy SW, Agbaje O, Tabar L, et al. Over-diagnosis and over-treatment of breast cancer: estimates of over-diagnosis from two trials of mammographic screening for breast cancer. Breast Cancer Res. 2005;7(6):258–65.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Ernster VL, Ballard-Barbash R, Barlow WE, et al. Detection of DCIS in women undergoing screening mammography. JNCI. 2002;94(20):1546–54.

    Article  PubMed  Google Scholar 

  6. May DS, Lee NC, Richardson LC, et al. Mammography and breast cancer detection by race and Hispanic ethnicity: results from a national program (United States). Cancer Causes Control. 2000;11(8):695–705.

    Article  Google Scholar 

  7. Howlader N, Noone A, Krapcho M, et al., editors. SEER Cancer Statistics Review, 1975–2008. Bethesda: National Cancer Institute. http://seer.cancer.gov/csr/1975–2008.

  8. CA Cancer J Clin. 2012 Jan-Feb; 62(1):10–29. doi: 10.3322/caac.20138. PMID: 22237781.

  9. Horner M, Rice L, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2006. Bethesda: National Cancer Institute; 2009.

    Google Scholar 

  10. Fisher ER, Dignam J, Tan-Chiu, et al. Pathologic findings from the NSABP 8-year follow-up of protocol B-17: intraductal carcinoma. Cancer. 1999;86(3):429–38.

    Article  CAS  PubMed  Google Scholar 

  11. Smith BD, Haffty BG, Buchholz TA, et al. Effectiveness of radiation therapy in older women with DCIS. J Natl Cancer Inst. 2006;98(18):1302–10.

    Article  PubMed  Google Scholar 

  12. Solin LJ, Fourquet A, Vicini FA, et al. Long-term outcome after breast conservation treatment with radiation for mammographically detected DCIS of the breast. Cancer. 2005;103(6):1137–46.

    Article  PubMed  Google Scholar 

  13. Solin LJ. The impact of adding radiation treatment after breast conservation surgery for ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr. 2010;41:187–92.

    Article  Google Scholar 

  14. Li CI, Malone KE, Saltzman BS, et al. Risk of invasive breast carcinoma among women diagnosed with DCIS and LCIS, 1998–2001. Cancer. 2006;106(10):2104–12.

    Article  PubMed  Google Scholar 

  15. Silverstein MJ. The University of Southern California/Van Nuys prognostic index for DCIS of the breast. Am J Surg. 2003;186(4):337–43.

    Article  PubMed  Google Scholar 

  16. Di Saverio S, Catena F, Santini D, et al. 259 patients with DCIS of the breast applying the USC/Van Nuys prognostic index: a retrospective review with long-term follow-up. Breast Cancer Res Treat. 2008;109(3):405–16.

    Article  PubMed  Google Scholar 

  17. Coburn NG, Chung MA, Fulton J, et al. Decreased breast cancer tumor size, stage and mortality in Rhode Island: an example of a well-screened population. Cancer Control. 2004;11(4):222–30.

    PubMed  Google Scholar 

  18. Li CI, Daling JR, Malone KE. Age-specific incidence rates of in situ breast carcinoma by histologic type, 1980–2001. Cancer Epidemiol Biomarkers Prev. 2005;14(4):1008–11.

    Article  PubMed  Google Scholar 

  19. Alvarado R, Lari SA, Roses RE, et al. Biology, treatment and outcome in very young and older women with DCIS. Ann Surg Oncol. 2012. doi:10.1245/s10434-012-2413-4. Published online: 24 May 2012.

    PubMed Central  Google Scholar 

  20. Claus EB, Stowe M, Carter D. Breast carcinoma in situ: risk factors and screening patterns. J Natl Cancer Inst. 2001;93(23):1811–7.

    Article  CAS  PubMed  Google Scholar 

  21. MacKenzie TA, Titus-Ernstoff L, Vacek PM, et al. Breast density in relation to risk of DCIS of the breast in women undergoing screening mammography. Cancer Causes Control. 2007;18(9):939–45.

    Article  PubMed  Google Scholar 

  22. Kerlikowske K, Barclay J, Grady D, et al. Comparison of risk factors for DCIS and invasive breast cancer. J Natl Cancer Inst. 1997;89(1):76–82.

    Article  CAS  PubMed  Google Scholar 

  23. Brekelmans CT, Seynaeve C, Bartels CC, et al. Effectiveness of breast cancer surveillance in BRCA ½ gene mutation carriers and women with high familial risk. J Clin Oncol. 2001;19(4):924–30.

    CAS  PubMed  Google Scholar 

  24. van Deurzen CHM, Hobbelink MGG, van Hillegersberg R, et al. Is there an indication for sentinel node biopsy in patients with DCIS of the breast? A review. Eur J Cancer. 2007;43(6):993–1001.

    Article  PubMed  Google Scholar 

  25. Kurniawan ED, Rose A, Mou A, et al. Risk factors for invasive breast cancer when core needle biopsy shows DCIS. Arch Surg. 2010;145(11):1098–104.

    Article  PubMed  Google Scholar 

  26. Erbas B, Provenzano E, Armes J, et al. The natural history of DCIS of the breast: a review. Breast Cancer Res Treat. 2006;97(2):135–44.

    Article  PubMed  Google Scholar 

  27. Sanders ME, Schuyler PA, Dupont WD, et al. The natural history of low-grade DCIS of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer. 2005;103(12):2481–4.

    Article  PubMed  Google Scholar 

  28. Minnesota Evidence-based Practice Center, Minneapolis, Minnesota. Diagnosis and management of ductal carcinoma in situ (DCIS). Evidence Report and Technology Assessment, No. 185, AHRQ Publication No. 09-E018, Sept 2009.

    Google Scholar 

  29. MacDonald HR, Silverstein MJ, Mabry H, et al. Local control in DCIS treated by excision alone: incremental benefit of larger margins. Am J Surg. 2005;190(4):521–5.

    Article  PubMed  Google Scholar 

  30. Kerlikowske K, Molinaro A, Cha I, et al. Characteristics associated with recurrence among women with DCIS treated by lumpectomy. J Natl Cancer Inst. 2003;95(22):1692–702.

    Article  PubMed  Google Scholar 

  31. Bijker N, Meijnen P, Peterse JL, et al. Breast conserving treatment with or without radiotherapy in DCIS: 10-year results of EORTC randomized phase 3 trial 10853-A study by the EORTC Breast Cancer Cooperative Group and the EORTC Radiotherapy Group. J Clin Oncol. 2006;24(21):3381–7.

    Article  PubMed  Google Scholar 

  32. Meretoja TJ, Heikkila PS, Salmenkivi K, et al. Outcome of patients with DCIS and sentinel node biopsy. Ann Surg Oncol. 2012;19:2345–51.

    Article  CAS  PubMed  Google Scholar 

  33. Lyons JM, Stempel M, Van Zee KJ, et al. Axillary node staging for microinvasive breast cancer: is it justified? Ann Surg Oncol. 2012;19:3416–21.

    Article  PubMed  Google Scholar 

  34. Shah DR, Canter RJ, Khatri VP, et al. Utilization of sentinel lymph node biopsy in patients with DCIS undergoing mastectomy. Ann Surg Oncol. 2012. doi:10.1245/s10434-012-2539-4.

    PubMed Central  Google Scholar 

  35. Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastasis. JAMA. 2011;305(6):569–75.

    Article  CAS  PubMed  Google Scholar 

  36. Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from NSABP B-17. J Clin Oncol. 1998;16(2):441–52.

    CAS  PubMed  Google Scholar 

  37. Fisher B, Land S, Mamounas E, Dignam ER, et al. Prevention of invasive breast cancer in women with DCIS: an update of the NSABP. Semin Oncol. 2001;28(4):400–18.

    Article  CAS  PubMed  Google Scholar 

  38. Wapnir I, Dignam J, Julian TB, et al. Long-term outcomes after invasive breast tumor recurrence (IBTR) in women with DCIS in NSABP B-17 and B-24. J Clin Oncol. 2007;25(suppl):7s.

    Google Scholar 

  39. Bijker N, Peterse JL, Duchateau L, et al. Risk factors for recurrence and metastasis after breast conserving therapy for DCIS: analysis of EORTC 10853. J Clin Oncol. 2001;19(8):2263–71.

    CAS  PubMed  Google Scholar 

  40. Holmberg L, Garmo H, Granstrand B, et al. Absolute risk reductions for local recurrence after post-operative radiotherapy after sector resection for DCIS of the breast. J Clin Oncol. 2008;26(8):1247–52.

    Article  PubMed  Google Scholar 

  41. Silverstein MJ, Lagios MD, Groshen S, et al. The influence of margin width on local control of DCIS of the breast. NEJM. 1999;340(19):1455–61.

    Article  CAS  PubMed  Google Scholar 

  42. Rudloff U, Brogi E, Reiner AS, et al. The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast-conserving surgery. Ann Surg. 2010;251(4):583–91.

    Article  PubMed  Google Scholar 

  43. Independent UK Panel on Breast Cancer Screening. The benefit and harms of breast cancer screening: an independent review. Lancet. 2012;380(9855):1778–86.

    Article  Google Scholar 

  44. Wallis MG, Clemets K, Kearins O, et al. The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS. Br J Cancer. 2012;106(10):1611–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  45. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367(21):1998–2005.

    Article  CAS  PubMed  Google Scholar 

  46. Kalager M, Adami HO, Bretthauer M, et al. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med. 2012;156:491–9.

    Article  PubMed  Google Scholar 

  47. Saunders ME, Schuyler PA, Dupont WD, et al. The natural history of low grade DCIS of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer. 2005;103:2481–4.

    Article  Google Scholar 

  48. Collins LC, Tamimi RM, Baer HJ, et al. Outcome of patients with DCIS untreated after diagnostic biopsy. Results from the Nurses’ Health Study. Cancer. 2005;103:1778–84.

    Article  PubMed  Google Scholar 

  49. Betsill WLJ, Rosen PP, Lieberman PH, et al. Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone. J Am Med Assoc. 1978;239:1863–7.

    Article  Google Scholar 

  50. King TA, Sakr RA, Muhsen S, et al. Is there a low-grade precursor pathway in breast cancer? Ann Surg Oncol. 2012;19:1115–21.

    Article  PubMed  Google Scholar 

  51. Lehman CD, Gatsonis C, Kuhl CK, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007;356:1295–303.

    Article  CAS  PubMed  Google Scholar 

  52. Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast cancer screening in women with a familial or genetic predisposition. N Engl J Med. 2004;351:427–37.

    Article  CAS  PubMed  Google Scholar 

  53. Schouten van der Velden AP, Boetes C, Bult P, et al. The value of MRI imaging in diagnosis and size assessment of in situ and small invasive breast carcinoma. Am J Surg. 2006;192:172–8.

    Article  PubMed  Google Scholar 

  54. Santamaria G, Velasco M, Farrus B, et al. Preoperative MRI of pure intraductal breast carcinoma-A valuable adjunct to mammography in assessing cancer extent. Breast. 2008;17:186–94.

    Article  PubMed  Google Scholar 

  55. Kuhl CK, Schrading S, Bieling HB, et al. MRI for diagnosis of pure DCIS: a prospective observational study. Lancet. 2007;370:485–92.

    Article  PubMed  Google Scholar 

  56. Fadare O, Clement NF, Ghofrani M. High and intermediate grade DCIS of the breast: a comparison of pathologic features in core biopsies and excisions and an evaluation of core biopsy features that may predict a close or positive margin in the excision. Diagn Pathol. 2009;4:26.

    Article  PubMed Central  PubMed  Google Scholar 

  57. Allen LR, Lago-Toro CE, Hughes JH, et al. Is there a role for MRI in the pre-operative assessment of patients with DCIS? Ann Surg Oncol. 2010;17:2395–400.

    Article  PubMed  Google Scholar 

  58. Kropcho LC, Steen ST, Chung AP, et al. Preoperative breast MRI in the surgical treatment of DCIS. Breast J. 2012;18(2):151–6.

    Article  PubMed  Google Scholar 

  59. Pilewskie M, Kennedy C, Shappell C, et al. Effect of MRI on the management of DCIS of the breast. Ann Surg Oncol. 2012. doi:10.1245/s10434-012-2771. Published online 07 Dec 2012.

    Google Scholar 

  60. Wang SY, Chu H, Shamliyan T, et al. Network meta-analysis of margin threshold for women with DCIS. J Natl Cancer Inst. 2012;104(7):507–16.

    Article  PubMed Central  PubMed  Google Scholar 

  61. Morrow M, Katz SJ. Margins in DCIS: is bigger really better? Editorials. J Natl Cancer Inst. 2012;104(7):494–5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Advocate Center for Breast Health, Advocate Cancer Institute, Advocate Christ Medical Center, 4400 West 95th Street, Suite 107 POB 408, Oak Lawn, IL, 60453, USA

    Adam I. Riker MD, FACS

  2. Breast Cancer Program, Advocate Cancer Institute, Advocate Christ Medical Center, 4400 West 95th Street, Oak Lawn, IL, 60453, USA

    Barbara L. Krueger MD, FACS

  3. Department of Pathology, Advocate Cancer Institute, Advocate Christ Medical Center, 4400 West 95th Street, Suite 107 POB 408, Oak Lawn, IL, 60453, USA

    Jami Walloch MD

Authors
  1. Adam I. Riker MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barbara L. Krueger MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jami Walloch MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adam I. Riker MD, FACS .

Editor information

Editors and Affiliations

  1. Advocate Center for Breast Health, Advocate Cancer Institute, Oak Lawn, Illinois, USA

    Adam I. Riker

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Riker, A.I., Krueger, B.L., Walloch, J. (2015). Current Management of Ductal Carcinoma In Situ (DCIS). In: Riker, A. (eds) Breast Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1145-5_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1145-5_11

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1144-8

  • Online ISBN: 978-1-4939-1145-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation